184 related articles for article (PubMed ID: 14531210)
1. Bosentan for pulmonary arterial hypertension.
Drug Ther Bull; 2003 Sep; 41(9):70-2. PubMed ID: 14531210
[TBL] [Abstract][Full Text] [Related]
2. [Blockade of endothelin receptor with bosentan--a new principle of treatment in pulmonary arterial hypertension].
Nielsen-Kudsk JE
Ugeskr Laeger; 2003 Jul; 165(29):2891-4. PubMed ID: 12908360
[TBL] [Abstract][Full Text] [Related]
3. Bosentan: a review of its use in the management of mildly symptomatic pulmonary arterial hypertension.
Dhillon S; Keating GM
Am J Cardiovasc Drugs; 2009; 9(5):331-50. PubMed ID: 19791841
[TBL] [Abstract][Full Text] [Related]
4. Bosentan: a dual endothelin receptor antagonist.
Rubin LJ; Roux S
Expert Opin Investig Drugs; 2002 Jul; 11(7):991-1002. PubMed ID: 12084009
[TBL] [Abstract][Full Text] [Related]
5. Treatment of pulmonary arterial hypertension with bosentan: from pathophysiology to clinical evidence.
Provencher S; Sitbon O; Simonneau G
Expert Opin Pharmacother; 2005 Jul; 6(8):1337-48. PubMed ID: 16013984
[TBL] [Abstract][Full Text] [Related]
6. Review on bosentan, a dual endothelin receptor antagonist for the treatment of pulmonary arterial hypertension.
Serasli E; Michaelidis V; Kosmas A; Antoniadou M; Tsara V
Recent Pat Cardiovasc Drug Discov; 2010 Nov; 5(3):184-95. PubMed ID: 20874675
[TBL] [Abstract][Full Text] [Related]
7. [Pharmacological characteristics and clinical efficacy of bosentan].
Fujimoto K; Ikenoya S
Nihon Yakurigaku Zasshi; 2005 Dec; 126(6):407-18. PubMed ID: 16462092
[No Abstract] [Full Text] [Related]
8. Bosentan.
Chin K; Channick R
Expert Rev Cardiovasc Ther; 2004 Mar; 2(2):175-82. PubMed ID: 15151466
[TBL] [Abstract][Full Text] [Related]
9. Bosentan.
Prakash A; Perry CM
Am J Cardiovasc Drugs; 2002; 2(5):335-43; discussion 343. PubMed ID: 14727963
[TBL] [Abstract][Full Text] [Related]
10. Bosentan.
Mathier MA; Ishizawar D
Expert Opin Pharmacother; 2010 Apr; 11(6):1023-34. PubMed ID: 20307226
[TBL] [Abstract][Full Text] [Related]
11. Bosentan therapy for pulmonary arterial hypertension.
Rubin LJ; Badesch DB; Barst RJ; Galie N; Black CM; Keogh A; Pulido T; Frost A; Roux S; Leconte I; Landzberg M; Simonneau G
N Engl J Med; 2002 Mar; 346(12):896-903. PubMed ID: 11907289
[TBL] [Abstract][Full Text] [Related]
12. Bosentan in the treatment of pulmonary arterial hypertension with the focus on the mildly symptomatic patient.
Valerio CJ; Coghlan JG
Vasc Health Risk Manag; 2009; 5():607-19. PubMed ID: 19688101
[TBL] [Abstract][Full Text] [Related]
13. Endothelin-I receptor antagonist for the treatment of pulmonary arterial hypertension in systemic sclerosis.
Varga J
Curr Rheumatol Rep; 2003 Apr; 5(2):145-6. PubMed ID: 12628045
[No Abstract] [Full Text] [Related]
14. Bosentan: a review of its use in pulmonary arterial hypertension and systemic sclerosis.
Oldfield V; Lyseng-Williamson KA
Am J Cardiovasc Drugs; 2006; 6(3):189-208. PubMed ID: 16780392
[TBL] [Abstract][Full Text] [Related]
15. [Pulmonary arterial hypertension. Therapy with the endothelin-1 receptor antagonist bosentan].
Musch A
Med Monatsschr Pharm; 2006 Jul; 29(7):242-5. PubMed ID: 16866076
[TBL] [Abstract][Full Text] [Related]
16. Meta-analysis of randomized controlled trials on treatment of pulmonary arterial hypertension.
He B; Zhang F; Li X; Tang C; Lin G; Du J; Jin H
Circ J; 2010 Jul; 74(7):1458-64. PubMed ID: 20519876
[TBL] [Abstract][Full Text] [Related]
17. Treatment of patients with mildly symptomatic pulmonary arterial hypertension with bosentan (EARLY study): a double-blind, randomised controlled trial.
Galiè N; Rubin Lj; Hoeper M; Jansa P; Al-Hiti H; Meyer G; Chiossi E; Kusic-Pajic A; Simonneau G
Lancet; 2008 Jun; 371(9630):2093-100. PubMed ID: 18572079
[TBL] [Abstract][Full Text] [Related]
18. Current status of bosentan for treatment of pulmonary hypertension.
Raja SG; Dreyfus GD
Ann Card Anaesth; 2008; 11(1):6-14. PubMed ID: 18182753
[TBL] [Abstract][Full Text] [Related]
19. Bosentan therapy for pulmonary arterial hypertension.
Cohen H; Chahine C; Hui A; Mukherji R
Am J Health Syst Pharm; 2004 Jun; 61(11):1107-19. PubMed ID: 15237563
[TBL] [Abstract][Full Text] [Related]
20. Effects of long-term bosentan in children with pulmonary arterial hypertension.
Rosenzweig EB; Ivy DD; Widlitz A; Doran A; Claussen LR; Yung D; Abman SH; Morganti A; Nguyen N; Barst RJ
J Am Coll Cardiol; 2005 Aug; 46(4):697-704. PubMed ID: 16098438
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
